

Columbia Research Enhanced Core ETF (NYSEARCA:RECS - Get Free Report)'s stock price reached a new 52-week high on Friday. The stock traded as high as $41.94 and last traded at $41.86, with a volume of 49467 shares trading hands. The stock had previously closed at $41.55. Columbia Research Enhanced Core ETF Stock Performance The

Ameriprise Financial Inc. boosted its holdings in shares of Columbia Research Enhanced Core ETF (NYSEARCA:RECS) by 1.8% during the undefined quarter, according to its most recent 13F filing with the SEC. The fund owned 13,203,009 shares of the company's stock after purchasing an additional 239,164 shares during the period. Ameriprise Financial Inc.

BlueStem Wealth Partners LLC lowered its position in Columbia Research Enhanced Core ETF (NYSEARCA:RECS) by 32.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 715,442 shares of the company's stock after selling 347,497 shares during the

Empirical Asset Management LLC lessened its holdings in Columbia Research Enhanced Core ETF (NYSEARCA:RECS) by 52.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 32,723 shares of the company's stock after selling 36,402 shares during the quarter. Empirical Asset Management

Atria Investments Inc increased its position in Columbia Research Enhanced Core ETF (NYSEARCA:RECS) by 9.9% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 209,020 shares of the company's stock after buying an additional 18,804 shares during the period. Atria Investments Inc owned about

Drake and Associates LLC boosted its stake in shares of Columbia Research Enhanced Core ETF (NYSEARCA:RECS) by 10.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 926,036 shares of the company's stock after purchasing an

Heck Capital Advisors LLC reduced its position in Columbia Research Enhanced Core ETF (NYSEARCA:RECS) by 5.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 436,869 shares of the company's stock after selling 25,053 shares during the quarter. Columbia Research Enhanced Core

Columbia Research Enhanced Core ETF tracks the index comprising the Russell 1000 constituents that demonstrate a convincing combination of quality, value, and catalyst factors. I maintain the Buy rating on RECS, owing to its robust performance (i.e., alpha delivered in 2025) and a GARP tilt manifested in a 1.15 PEG ratio. Risks include the AI economy names underdelivering, as well as higher inflation and slower-than-expected interest rate cuts.